Document is current
Any future updates will be listed below
-
Authors
Moradi, Ali https://orcid.org/0000-0003-4169-0354
Zare, Fatemeh https://orcid.org/0000-0003-0788-6732
Mostafavinia, Atarodsadat https://orcid.org/0000-0003-2270-5637
Safaju, Sobhan https://orcid.org/0000-0003-3072-4272
Shahbazi, Amirhossein https://orcid.org/0000-0003-2229-5295
Habibi, Malihe https://orcid.org/0000-0003-0939-7238
Abdollahifar, Mohammad-Amin https://orcid.org/0000-0001-6947-3285
Hashemi, Seyed Mahmoud https://orcid.org/0000-0003-1389-5803
Amini, Abdollah https://orcid.org/0000-0002-9408-3200
Ghoreishi, Seyed Kamran https://orcid.org/0000-0003-4998-6707
Chien, Sufan https://orcid.org/0000-0002-1067-4178
Hamblin, Michael R. https://orcid.org/0000-0001-6431-4605
Kouhkheil, Reza https://orcid.org/0000-0003-0261-085X
Bayat, Mohammad https://orcid.org/0000-0001-5214-4223
-
Funding
Funding for this research was provided by:
Shahid Beheshti University of Medical Sciences (14602)
National Institute for Medical Research Development (971122)
National Institute for Medical Research Development (971122)
NIH (DK105692)
NIH (R01AI050875 R21AI121700)
- License Information
-
More Information
Article History
Received: 3 September 2019
Accepted: 31 December 2019
First Online: 27 January 2020
Competing interests
: We declare that only Michael R Hamblin has some potential conflicts of interest: Scientific Advisory Boards: Transdermal Cap Inc, Cleveland, OH; BeWell Global Inc, Wan Chai, Hong Kong; Hologenix Inc. Santa Monica, CA; LumiThera Inc, Poulsbo, WA; Vielight, Toronto, Canada; Bright Photomedicine, Sao Paulo, Brazil; Quantum Dynamics LLC, Cambridge, MA; Global Photon Inc, Bee Cave, TX; Medical Coherence, Boston MA; NeuroThera, Newark DE; JOOVV Inc, Minneapolis-St. Paul MN; AIRx Medical, Pleasanton CA; FIR Industries, Inc. Ramsey, NJ; UVLRx Therapeutics, Oldsmar, FL; Ultralux UV Inc, Lansing MI; Illumiheal & Petthera, Shoreline, WA; MB Laser therapy, Houston, TX; ARRC LED, San Clemente, CA; Varuna Biomedical Corp. Incline Village, NV; Niraxx Light Therapeutics, Inc, Boston, MA. Consulting; Lexington Int, Boca Raton, FL; USHIO Corp, Japan; Merck KGaA, Darmstadt, Germany; Philips Electronics Nederland B.V. Eindhoven, Netherlands; Johnson & Johnson Inc, Philadelphia, PA; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Stockholdings: Global Photon Inc, Bee Cave, TX; Mitonix, Newark, DE. We declare that other authors: Mohammad Bayat, Ali Moradi, Fatemeh Zare, Ataroalsadat Mostafavinia, Reza Kouhkheil, Sobhan Safaju, Amirhossein Shahbazi, Malihe Habibi, Seyed Mahmoud Hashemi, Abdollah Amini, Mohammad-Amin Abdollahifar, Seyed Kamran Ghoreishi, and Sufan Chien, don’t have any conflict of interest at all.
